Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice

Autor: Antonino Cattaneo, Gianluca Amato, Domenico Vignone, Cecilia Tiveron, Simona Capsoni
Přispěvatelé: Capsoni, Simona, Tiveron, C, Amato, G, Vignone, D, Cattaneo, Antonino
Rok vydání: 2010
Předmět:
Genetically modified mouse
Superior cervical ganglion
Tyrosine 3-Monooxygenase
Transgene
Central nervous system
Socio-culturale
Enzyme-Linked Immunosorbent Assay
Mice
Transgenic

Superior Cervical Ganglion
Neuropsychological Tests
Biology
Transfection
Blood–brain barrier
Antibodies
Choline O-Acetyltransferase
Amyloid beta-Protein Precursor
Mice
Parasympathetic Nervous System
Chlorocebus aethiops
Nerve Growth Factor
medicine
Animals
Humans
Autoantibodies
Analysis of Variance
Memory Disorders
Amyloid beta-Peptides
General Neuroscience
Neurodegeneration
Recognition
Psychology

General Medicine
medicine.disease
Mice
Inbred C57BL

Disease Models
Animal

Psychiatry and Mental health
Clinical Psychology
medicine.anatomical_structure
Nerve growth factor
nervous system
Blood-Brain Barrier
COS Cells
Nerve Degeneration
Immunology
Cholinergic
Immunoglobulin Light Chains
Geriatrics and Gerontology
Zdroj: Journal of Alzheimer's Disease. 20:527-546
ISSN: 1875-8908
1387-2877
DOI: 10.3233/jad-2010-091357
Popis: We previously showed that anti-nerve growth factor (NGF) antibodies expressed in transgenic mice (AD11) elicit a progressive neurodegeneration, comprising the triad of Alzheimer's disease (AD) hallmarks: cholinergic loss, tau hyperphosphorylation, and amyloid-beta peptide formation. However, since anti-NGF antibodies are produced both in the brain and in peripheral tissues of AD11 mice, the contribution of peripheral neutralization of NGF to the onset of brain neurodegeneration was still unexplored. To address this question, we characterized a line of transgenic mice (AD10) in which anti-NGF antibodies are obligatorily produced only in lymphocytes, being initially found in blood. In AD10 mice, peripheral NGF neutralization elicits shrinkage of superior cervical ganglia (immunosympathectomy) and, as a consequence of this, peripheral anti-NGF antibodies cross the blood brain barrier (BBB) and reach the brain, generating an NGF-dependent neurodegeneration, largely superimposable to that observed in AD11 mice. This demonstrates that peripherally originated anti-NGF antibodies can generate a neurodegeneration in the central nervous system of an animal model. Consistently, peripherally-delivered NGF is effective in preventing the onset of the central cholinergic deficit. These findings could have a direct relevance for some human sporadic AD cases, highlighting the role of the BBB disruption and suggesting a causally relevant role of circulating antibodies in AD pathology.
Databáze: OpenAIRE